Pyrogallol-induced As4.1 juxtaglomerular cell death is attenuated by MAPK inhibitors via preventing GSH depletion

Yong Hwan Han; Woo Hyun Park
August 2010
Archives of Toxicology;Aug2010, Vol. 84 Issue 8, p631
Academic Journal
Pyrogallol (PG) induces apoptosis in several types of cells mediated by superoxide anion (O). Here, we investigated the effects of PG and/or MAPK (MEK, JNK, and p38) inhibitors on the changes in cell growth, cell death, reactive oxygen species (ROS), and GSH levels in As4.1 juxtaglomerular (JG) cells. PG inhibited the growth of As4.1 cells. It also induced apoptosis and the loss of mitochondrial membrane potential (MMP; ΔΨm) and increased the level of p53 protein. Intracellular O level was increased in PG-treated As4.1 cells. PG also increased the number of GSH deleted cells in As4.1 cells. All the MAPK inhibitors significantly attenuated the growth inhibition and death mediated by PG. They decreased the levels of p53 protein and MMP (ΔΨm) loss in PG-treated As4.1 cells. They also reduced O level and GSH-depleted cell number in these cells. In conclusion, MAPK inhibitors attenuated As4.1 cell growth inhibition and death mediated by PG treatment. The changes in O and GSH levels by PG and/or MAPK inhibitors appeared to affect the growth and death of As4.1 cells.


Related Articles

  • Potentiation of Fas-mediated apoptosis by attenuated production of mitochondria-derived reactive oxygen species. Aronis, A; Melendez, J Andr's; Golan, O; Shilo, S; Dicter, N; Tirosh, O // Cell Death & Differentiation;Mar2003, Vol. 10 Issue 3, p335 

    The role of reactive oxygen species (ROS) production in death receptor-mediated apoptosis is ill-defined. Here, we show that ROS levels play a role in moderating Fas-dependent apoptosis. Treatment of Jurkat T cells with oligomycin (ATP-synthase inhibitor) or (mitochondrial uncoupler) and...

  • Modulation of apoptosis of mononuclear cells under conditions of oxidative stress. V. Novitsky; N. Ryazantseva; N. Chasovskih; E. Starikova; E. Kaygorodova; Yu. Starikov; O. Jukova // Bulletin of Experimental Biology & Medicine;Mar2008, Vol. 145 Issue 3, p283 

    Abstract  We studied mitochondrial and type 1 tumor necrosis factor-α receptor (TNFR1)-mediated pathways triggering the apoptotic program in mononuclear cells under conditions of oxidative stress. Intensification of intracellular production of reactive oxygen forms is accompanied by an...

  • Inhibition of β-oxidative respiration is a therapeutic window associated with the cancer chemo-preventive activity of PPARγ agonists Andela, Valentine B.; Altuwaijri, Saleh; Wood, James; Rosier, Randy N. // FEBS Letters;Mar2005, Vol. 579 Issue 7, p1765 

    Abstract: We demonstrate expression and coordinate induction of PPARγ and lipogenic enzymes (HMG-CoA synthase, HMG-CoA reductase and fatty acid synthase) in a murine lung alveolar carcinoma cell line (Line 1) treated with the PPARγ agonist troglitazone (TRO) [0–100μM]. We...

  • Regulation of singlet oxygen-induced apoptosis by cytosolic NADP-dependent isocitrate dehydrogenase. Sun Kim; Su Lee; Jean Tak; Kyeong Choi; Taeg Kwon; Jeen-Woo Park // Molecular & Cellular Biochemistry;Aug2007, Vol. 302 Issue 1/2, p27 

    Abstract  Singlet oxygen is a highly reactive form of molecular oxygen that may harm living systems by oxidizing critical cellular macromolecules and it also promotes deleterious processes such as cell death. Recently, we demonstrated that the control of redox balance and the...

  • Induction of apoptosis in HepG2 cells by polysaccharide MEP-II from the fermentation broth of Morchella esculenta. Hu, Meili; Chen, Yan; Wang, Cui; Cui, Huali; Duan, Peilu; Zhai, Tianlong; Yang, Yuling; Li, Shaofei // Biotechnology Letters;Jan2013, Vol. 35 Issue 1, p1 

    A novel polysaccharide, MEP-II, isolated from the fermentation broth of Morchella esculenta inhibited the proliferation of human hepatoma cell line (HepG2) through an apoptotic pathway. After HepG2 cells were treated with 150-600 μg MEP-II/ml, typical apoptotic characteristics including...

  • Minocycline and Cytoprotection: Shedding New Light on a Shadowy Controversy. Jordan, J.; Fernandez-Gomez, F. J.; Ramos, M.; Ikuta, I.; Aguirre, N.; Galindo, M. F. // Current Drug Delivery;Sep2007, Vol. 4 Issue 3, p225 

    In this review we explore and integrate the knowledge of the plausible pharmacological targets that could explain the new application for the well known semi-synthetic, tetracycline-derivate minocycline as a cytoprotective drug. In doing so, we will analyze the possible mechanisms to elucidate...

  • Aging as a Mitochondria-Mediated Atavistic Program: Can Aging Be Switched Off? SKULACHEV, VLADIMIR P.; LONGO, VALTER D. // Annals of the New York Academy of Sciences;2005, Vol. 1057 Issue 1, p145 

    Programmed death phenomena have been demonstrated on subcellular (mitoptosis), cellular (apoptosis), and supracellular (collective apoptosis) levels. There are numerous examples of suicide mechanisms at the organismal level (phenoptosis). In yeast, it was recently shown that the death of aging...

  • Cell-Type Restricted Responses to Chronic Oxidative Stress. Roper, Jason M.; O'Reilly, Michael A. // Current Respiratory Medicine Reviews;2006, Vol. 2 Issue 3, p313 

    Exposure to hyperoxia (> 95% O2) is a necessary therapeutic treatment used to maintain tissue oxygenation in patients with compromised lung function and decreased pulmonary gas exchange. Hyperoxia causes increased formation of reactive oxygen species (ROS), which accumulate in the cells of the...

  • Cell Death by Necrosis, a Regulated Way to Go. Henriquez, Mauricio; Armis�n, Ricardo; Stutzin, Andres; Quest, Andrew F.G. // Current Molecular Medicine;May2008, Vol. 8 Issue 3, p187 

    Apoptosis is a programmed form of cell death with well-defined morphological traits that are often associated with activation of caspases. More recently evidence has become available demonstrating that upon caspase inhibition alternative programs of cell death are executed, including ones with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics